Skin Therapy Letter HOME
Written for dermatologists by dermatologists. Indexed by the US National Library of Medicine.
Skin Information
Skin Therapy Letter About STL Subscribe Today SkinCareGuide Network Site Map

Skin Therapy Letter: Volume 22 - 2017

  Number 6 • Novmeber-December 2017   |  Download PDF

Dupilumab for Moderate-to-Severe Atopic Dermatitis
Ramya Vangipuram, MD1,2 and Stephen K. Tyring, MD, PhD1,2
1Center for Clinical Studies, Houston, TX, USA
2Department of Dermatology, University of Texas Health Sciences Center, Houston, TX, USA

Real-World Efficacy of Azelaic Acid 15% Gel for the Reduction of Inflammatory Lesions of Rosacea
Paul J. Wirth, MD1; Meagan-Helen Henderson Berg2; Neil Sadick, MD, FAAD, FAACS, FACP, FACPh3
1University of Buffalo, Buffalo, NY, USA
2McGill University, Montreal, QC, Canada
3Department of Dermatology, Weill Medical College of Cornell University, New York, NY, USA

Update on Drugs and Drug News - November-December 2017

  Number 5 • September-October 2017   |  Download PDF

Vitamin B Derivative (Nicotinamide) Appears to Reduce Skin Cancer Risk
Safia Nazarali, MSc and Paul Kuzel, MD, FRCPC
University of Alberta, Faculty of Medicine and Dentistry, Edmonton, AB, Canada

Epidermal Growth Factor Receptor Inhibitors: Cutaneous Side Effects and Their Management
Seena Monjazeb, MD; Janice Wilson, MD; Brent Kelly, MD
School of Medicine, Department of Dermatology, The University of Texas Medical Branch, Galveston, TX, USA

Update on Drugs and Drug News - September-October 2017

  Number 4 • July-August 2017   |  Download PDF

Secukinumab in the Treatment of Psoriasis and Psoriatic Arthritis: A Review of the Literature
Michael Abrouk, MD1; Jessica Gandy, MD1; Mio Nakamura, MD2; Kristina Lee, MS2; Merrick Brodsky, MD1; Rasnik Singh, MD3; Henry Zhu, MD4; Benjamin Farahnik, MD5; Tina Bhutani, MD2; John Koo, MD2
1Irvine School of Medicine, University of California, CA, USA
2Department of Dermatology, Psoriasis and Skin Treatment Center, University of California - San Francisco, San Francisco, CA, USA
3David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, CA, USA
4Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA
5The Larner College of Medicine, University of Vermont, Burlington, VT, USA

Hepatitis B and C Viruses and Biologics
Parbeer Grewal MD, FRCPC, FAAD1 and Ravina Sanghera, PharmD2
1Division of Dermatology, Department of Medicine, University of Calgary, Calgary, AB, Canada
2Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, AB, Canada

Update on Drugs and Drug News - July-August 2017

  Number 3 • May-June 2017   |  Download PDF

Psoriasis, Depression, and Suicidality
Mathew N. Nicholas, BMSc1 and Melinda Gooderham, MD, MSc, FRCPC2,3
1University of Toronto, Faculty of Medicine, Toronto, ON, Canada
2Skin Centre for Dermatology, Peterborough, ON, Canada
3Probity Medical Research, Waterloo, ON, Canada

The Role of Skin Care in Optimizing Treatment of Acne and Rosacea
Catherine Zip, MD, FRCPC
Division of Dermatology, Department of Medicine, University of Calgary, Calgary, AB, Canada

Update on Drugs and Drug News: May-June 2017

  Number 2 • March-April 2017   |  Download PDF

Tofacitinib in the Treatment of Rheumatoid Arthritis and Chronic Plaque Psoriasis
Aditya K. Gupta, MD, PhD, FRCP(C)1,2; Maria Cernea, PhD2; Charles W. Lynde, MD, FRCP(C)1,3
1University of Toronto Department of Medicine, Toronto, ON, Canada
2Mediprobe Research Inc., London, ON, Canada
3Lynde Institute for Dermatology, Markham, ON, Canada

A Review of Guselkumab, an IL-23 Inhibitor, for Moderate-to-Severe Plaque Psoriasis
Zeena Nawas, MD1; Michael Hatch, MD2; Elmira Ramos1; Melinda Liu3; Yun Tong, MD1,4; Andrew Peranteau, MD1; Stephen Tyring, MD, PhD1,5
1Center For Clinical Studies, Houston, TX, USA
2Texas Tech School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA
3Baylor College of Medicine, Houston, TX, USA
4Department of Dermatology, University of California San Diego, La Jolla, CA, USA
5Department of Dermatology, University of Texas Health Science Center, Houston, TX, USA

Skin Treatments Introduced in 2016

Update on Drugs and Drug News: March-April 2017

  Number 1 • January-February 2017   |  Download PDF

Dermatologist's Guide to Infection Screening Prior to Initiating Immunosuppressive Therapy
Marisa G. Ponzo, MD, PhD1 and Chih-Ho Hong, MD, FRCPC1,2
1Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada
2Division of Dermatology, St. Paul’s Hospital, Vancouver, BC, Canada

Update on Drugs and Drug News: January-February 2017